BRCA1 gene mutation carcinogenic risk analysis released

Author: Zhang Meng Ran Release Date: 2018-09-26

According to an oncology study published online by the British journal Nature recently, the American team of scientists has performed an unprecedented classification of thousands of BRCA1 gene variants by function, reporting the results of the carcinogenic risk analysis of BRCA1 gene variants. This "functional score" has clinical significance for the interpretation of genetic testing for screening for breast cancer and ovarian cancer risk.

BRCA1 is a human tumor suppressor gene that is responsible for maintaining the stability of the cell genome and preventing the accumulation of genetic mutations that regulate cell proliferation and tumor growth. Mutations in which BRCA1 loses function are thought to be associated with predisposition to early-onset breast and ovarian cancer. Up to now, although there have been thousands of BRCA1 gene mutations, many of them have been classified as “unknown mutations”, which poses a huge challenge to the assessment of human cancer risk.

To clarify these unclear variations, one of the methods is to detect whether the expression of the variant gene has the function of restoring DNA repair, which is part of the tumor suppression process. In light of this, University of Washington researcher Jay Schinder and colleagues used genome editing techniques to perform nearly 4,000 single nucleotide variants (SNV) functions on 13 exons critical for BRCA1 gene function. Evaluation and subsequent cell viability assays were performed in 20 million human haploid (HAP1) cells.

Finally, the team identified about 300 SNVs that interfered with expression and more than 400 missense mutations in SNV (which led to changes in the Amino Acid sequence of the protein) and found that these variants have no actual function (without destroying the original function of the gene) . These functional scores are closely related to the clinical assessment of known pathogenic or benign variants.

The researchers point out that the HAP1 cell line may not be the physiologically optimal model compared to other cell lines, but the data is highly correlated with clinical evaluation. The National Cancer Institute scientists affirmed the important value of “functional scores” for the classification of mutations, and concluded that the results can be directly applied to the interpretation of BRCA1 genetic screening.

Source: Technology Daily

Natural Extract Powder

Fruit and vegetable powder is processed by more than 10 processes such as pretreatment, quick freezing, vacuum drying, ultraviolet sterilization, packaging and storage, etc. 1. Low moisture content, which can prolong the storage period and reduce the cost of storage, transportation and packaging; 2. The utilization rate of raw materials is high, and it does not require high raw materials, especially the size and shape of raw materials; 3. Processing Special attention should be paid to removing the rotten parts of fruits and vegetables (completely remove strong carcinogens such as aflatoxin and patulin). At the same time, the residual pesticides in fruits and vegetables are completely removed. After removing these side effects, the prepared fruit and vegetable powder broadens the application scope of the raw materials of fruit and vegetables, and has little nutritional loss. Studies have shown that fruit and vegetable powder can be applied to almost all fields of food processing, and can be used to improve the nutritional content of products, improve the color and flavor of products, etc.

Natural Extract powder,Bulk Alpha Arbutin Powder,Resveratrol Benefits Powder,Setipiprant Buy Online,Evodiamine.

Xi'an Henrikang Biotech Co.,Ltd , https://www.henruikangbio.com

Posted on